TMO
Thermo Fisher Scientific Inc.Company with tickers: TMO
CIK
97745
CUSIP
883556102
Shares Outstanding
371,621,465
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $10,364,000,000 | USD | 2025-03-29 | 10-Q | 2026-05-01 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $342,000,000 | USD | 2025-03-29 | 10-Q | 2026-05-01 |
| Operating Income | $1,716,000,000 | USD | 2025-03-29 | 10-Q | 2026-05-01 |
| Net Income | $1,507,000,000 | USD | 2025-03-29 | 10-Q | 2026-05-01 |
| EPS (Basic) | $3.99 | USD/shares | 2025-03-29 | 10-Q | 2026-05-01 |
| EPS (Diluted) | $3.98 | USD/shares | 2025-03-29 | 10-Q | 2026-05-01 |